Takeda

New vaccine may save day for ill passengers
Star Phoenix, Canada
Sun, 07/14/13 - 11:39 am
norovirus
Takeda
vaccines
Common Acid Reflux Drugs May Lead To Heart Disease, New Research Suggests
Forbes
Fri, 07/12/13 - 08:41 am
acid reflux
proton pump inhibitors
Nexium
Prevacid
GERD
Prilosec
AstraZeneca
Takeda
Takeda Withdraws MAA for Omontys in Europe
NASDAQ
Sat, 07/6/13 - 12:30 pm
Takeda
Omontys
chronic kidney disease
Sucampo Receives $10 Million Milestone Payment from Takeda on First Sale of AMITIZA® (lubiprostone) for OIC in the US
Yahoo
Thu, 06/27/13 - 10:34 am
Sucampo
Takeda
Amitiza
opioid-induced constipation
Glaxo Diabetes Drug Didn’t Beat Takeda's Actos in Trial
Bloomberg
Mon, 06/24/13 - 11:09 am
GSK
diabetes
Takeda
Actos
albiglutide
Takeda Launches Diabetes Drugs
Zacks
Sat, 06/22/13 - 10:44 am
Takeda
Nesina
Kazano
Oseni
Takeda files BLA for vedolizumab for Crohn's and ulcerative colitis in USA
The Pharma Letter
Sat, 06/22/13 - 10:38 am
Takeda
vedolizumab
Chron's Disease
ulcerative colitis
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Takeda Pharmaceuticals Gets 6.5 Million Actos Judgment Overturned
SBWire
Sun, 06/9/13 - 09:43 am
Takeda
legal
lawsuit
Actos
Takeda And The Millenium Reorganization: Protopapas Explains
Pharmalot
Fri, 06/7/13 - 05:53 pm
Takeda
Millenium
reorganization
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Takeda, Biogen, Article One: Intellectual Property
Bloomberg
Fri, 05/31/13 - 09:07 am
Takeda
Biogen Idec
intellectual property
Novartis
Dexilant
generics
Sandoz
Tecfidera
Impax Laboratories
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim
Astellas forecasts big sales growth as prostate drug catches hold
Fierce Pharma
Mon, 05/13/13 - 12:27 pm
Astellas
Xtandi
Daiichi Sankyo
Japan
Takeda
prostate cancer
Takeda forecasts 28% slide in profit on weak sales
Marketwatch
Thu, 05/9/13 - 09:43 am
earnings
Takeda
Takeda Gets $6.5 Million Diabetes-Drug Verdict Thrown Out
Bloomberg
Thu, 05/2/13 - 10:38 am
diabetes
Takeda
Actos
bladder cancer
Jury hits Takeda with $6.5M judgment in first Actos liability case
Fierce Pharma
Mon, 04/29/13 - 12:59 pm
Actos
Takeda
bladder cancer
diabetes
Takeda in more trouble at home over recall of mislabeled vials
Fierce Pharma
Fri, 04/19/13 - 12:07 pm
Takeda
recalls
FDA saw early reports of severe Omontys reactions: WSJ
Fierce Pharma
Mon, 04/1/13 - 11:20 am
FDA
Omontys
Affymax
anemia
Takeda
Takeda seeks Japanese approval for brentuximab vedotin to treat relapsed/refractory CD30 positive HL and ALCL
Pharmabiz
Sat, 03/23/13 - 10:15 am
Takeda
brentuximab vedotin
systemic anaplastic large cell lymphoma

Pages